FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/12/2024
Voltar para busca
Dado oficial do USPTO
TESTOPRIME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
14/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
22/09/2022
Data de registro
18/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/06/2024
Última transação
04/07/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
ABID, NABEELA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Bauer Holdings Limited
Representantes
Howard Shipley Gordon Rees Scully Manshukhani LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Food supplements for use in relation to energyexercisehealthfitnessbeautywellbeingbodybuildingall of the foregoing in drop formpowder formcapsule formtablet formin liquid form; dietary and nutritional supplements; pharmaceutical preparations for building muscle and increasing testosterone levels; medical preparationsvitamin and mineral preparations for medical use; dietetic foods adapted for medical use and dietetic substances in the nature of dietetic preparations adapted for medical purposes; dietetic preparations adapted for medical purposes; food supplement capsules; dietary supplements and dietetic preparations adapted for medical purposes; nutritional and dietary supplements for humans; powdered nutritional supplement drink mix; protein powder dietary supplementspowdered nutritional supplement drink mix containing protein; protein supplement shakes; vitamin and mineral supplements; meal replacement drink mix powders adapted for medical use; meal replacement bars adapted for medical use; meal replacement drink mixes adapted for medical use; dietary food in the nature of dietary supplemental drinks; dietary and nutritional supplement drink mixes and powdered nutritional supplement drink mix; nutraceuticals for use as a nutritional and dietary supplement; flavourings and solutions being nutritional supplementsliquid nutritional supplement and powdered nutritional supplement concentrate; nutritional and dietetic food and substances for medical usemeal replacement bars adapted for medical usemeal replacement beverages adapted for medical use; nutrition and diet supplementsdietary and nutritional supplements
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/11/2024
FIMP
FINAL DISPOSITION PROCESSED
23/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
14/07/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/07/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
18/06/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
26/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
26/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2024
ALIE
ASSIGNED TO LIE
26/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/09/2023
GNRT
NON-FINAL ACTION E-MAILED
15/09/2023
CNRT
NON-FINAL ACTION WRITTEN
15/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/09/2023
RFNT
REFUSAL PROCESSED BY IB
07/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/07/2023
RFRR
REFUSAL PROCESSED BY MPU
10/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/06/2023
CNRT
NON-FINAL ACTION WRITTEN
05/06/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
05/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/06/2023
CNRT
NON-FINAL ACTION WRITTEN
02/06/2023
DOCK
ASSIGNED TO EXAMINER
01/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/10/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
13/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TESTOPRIME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.